Compulsory License of Pharmaceutical Patents in India : Natco Finds Safe Harbour in Bayer v. Union of India and Others

In Bayer Corporation v. Union of India and others, the High Court of Bombay affirmed the decision of the Controller of Patents and Intellectual property Appellate Board to grant Compulsory License in favour of Natco Pharma. This decision has firmly established India’s first compulsory license in the post TRIPS era since a Special Leave Petition by Bayer Corporation against the final judgment and order of the High Court has been dismissed by the Supreme Court of India recently